| DB ID | MyCo_3911 |
| Title | Unexpected decrease in total IgE in a patient with allergic bronchopulmonary aspergillosis treated with omalizumab |
| Year | 2014 |
| PMID | 24565782 |
| Fungal Diseases involved | Allergic bronchopulmonary aspergillosis |
| Associated Medical Condition | None |
| Genus | Aspergillus |
| Species | fumigatus |
| Organism | Aspergillus fumigatus |
| Ethical Statement | None |
| Site of Infection | None |
| Opportunistic invasive | Invasive |
| Sample type | Body fluid |
| Sample source | Serum |
| Host Group | Human |
| Host Common name | Human |
| Host Scientific name | Homo sapiens |
| Biomarker Name | Total IgE+omalizumab |
| Biomarker Full Name | Total Immunoglobulin E+ omalizumab |
| Biomarker Type | Diagnostic |
| Biomolecule | Protein |
| Geographical Location | Nashville, Tenn |
| Cohort | A now 80-year-old, 66-kg man presented 3 years ago with lifelong cough and chest congestion, and a history of recent hospitalization for right and possible bilateral lower lobe pneu- monia. |
| Cohort No. | 1 |
| Age Group | 80 |
| P Value | None |
| Sensitivity | None |
| Specificity | None |
| Positive Predictive Value | None |
| MIC | None |
| Fold Change | None |
| Pathway | None |
| Disease Introduction Mechanism | None |
| Technique | Immunological assay |
| Analysis Method | ImmunoCAP assay |
| ELISA kits | None |
| Assay Data | None |
| Validation Techniques used | ImmunoCAP assay |
| Up Regulation Down Regulation | Decrease |
| Sequence Data | None |
| External Link | None |
